RESEARCH

Total. 10

  • NO.
    Project name
    Business name
    Development details
    Performance period
  • 1
    Development of a Research Model Platform for Resistant Cancer
    Cooperative Convergence Science and Technology Promotion Support Project
    By linking human-derived digital information with the value chain between companies based on the immune humanized disease model animal system, the R&D RFP report aims to establish a resistant cancer research model platform and implement a new service business mediated by research associations
    2025. 04 ~ 2025. 12
  • 2
    Development of multiple simultaneous rapid diagnostic kits and on-site small reading systems for major drugs
    SME Technology Innovation and Development Project
    Multiple (20 types) simultaneous rapid diagnosis kits for major drug substances that have recently become a problem and development of a high-sensitivity multipurpose POCT analysis device
    2024. 08 ~ 2026. 07
  • 3
    Development of hepatitis B virus (HBV) cccDNA inhibitors using endoplasmic reticulum stress derivatives based on drug re-creation research
    Infectious Disease Prevention and Treatment Technology Development Project
    The purpose of this study is to treat intractable HBV patients by developing PERK-IFN signal-induced HBV cure agents that can remove discovered variants and cccDNA.
    2024. 07 ~ 2025. 12
  • 4
    Study on the establishment of biomarkers and the mechanism of human hazard by exposure to hemp oil
    Biomedical Technology Development Project
    Scientific evidence suggestion for government policy establishment on regulation of cannabis use and treatment by verifying human risk during hemp oil vaping through qualitative and quantitative analysis of harmful substances contained in hemp oil
    2023. 04 ~ 2027. 12
  • 5
    Development of evaluation indicators for the efficacy of next generation TB vaccine
    Development of Infectious Disease Prevention and Treatment Technology
    To save a lot of money and time to evaluate the effectiveness of a vaccine, we want to discover indicators that can evaluate more useful tuberculosis vaccines in advance and develop diagnostic methods using them
    2023. 04 ~ 2024. 12
  • 6
    Development and application of new cell counters to improve scRNA-Seq Service
    R&D service voucher project
    Developing cell counter equipment to increase cell QC accuracy using cell QC image analysis system advancement for scRNA-Seq experiment
    2023. 05 ~ 2024. 04
  • 7
    Development of LFA kit for detection and diagnosis of house dust mite allergens that can be used as indicators for improving residential environment
    Seoul Metropolitan Government Technical Commercialization Support Project
    Develop a kit that helps prevent allergic diseases and public health activities by simply checking the condition of house dust mites in the living environment within 15 minutes with an immunochemical method
    2021. 08 ~ 2022. 01
  • 8
    Development of new indicators for efficient evaluation of tuberculosis vaccine
    Development of Infectious Disease Prevention and Treatment Technology
    Various tuberculosis prevention vaccines are being developed to replace the existing BCG vaccines that show limited efficacy only to infants and young children. Accordingly, the systematic immune response to the tuberculosis vaccine is evaluated and an indicator that can predict the efficacy of the tuberculosis prevention vaccine is developed using this
    2020. 12 ~ 2022. 12
  • 9
    Development of multi-drug detection rapid kit and fully automated and portable drug test analyzer
    SME Technology Innovation and Development Project
    Development of multi-drug detection rapid kits and fully automated portable drug test analyzer that can quickly and easily determine drugs on site for easy access samples such as saliva using drug specific antibody and lateral flow immuno assay technology
    2020. 07 ~ 2022. 07
  • 10
    Developing diagnosis kit for detecting drugs and toxic chemicals
    Chonnam Natioanl University R&DB Foundation
    Mutiplex lateral flow immuno assay kit development for simultaneous analysis of more than 4 kinds of antibody to detect multi frequent drugs and toxic chemicals
    2019. 07 ~ 2019. 12

* Swipe left or right